Prevalence of adverse drug reaction with first-line drugs among patients treated for pulmonary tuberculosis
Authors:
- Abhijeet SinghASAbhijeet Singh
- Rajendra PrasadRPRajendra Prasad
- Viswesvaran BalasubramanianVBViswesvaran Balasubramanian
- Nikhil GuptaNGNikhil Gupta
- Pawan GuptaPGPawan Gupta
Open Access
- 1 January 2015
- journal article
- Published by Elsevier in Clinical Epidemiology and Global Health
- Vol. 3, S80-S90
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Adverse Reactions Due to Directly Observed Treatment Strategy Therapy in Chinese Tuberculosis Patients: A Prospective StudyPLOS ONE, 2013
- Isoniazid related gynecomastia: Description of a case and systematic review of literatureLung India, 2012
- Pyrazinamide induced thrombocytopeniaIndian Journal of Pharmacology, 2010
- Isoniazid- and ethambutol-induced psychosisAnnals of Thoracic Medicine, 2008
- Adverse events and treatment interruption in tuberculosis patients with and without HIV co-infectionThorax, 2006
- Deleterious influence of pyrazinamide on the outcome of patients with fulminant or subfulminant liver failure during antituberculous treatment including isoniazidHepatology, 1995
- Pyrazinamide induced thrombocytopeniaTubercle, 1988
- Hepatic toxicity in south indian patients during treatment of tuberculosis with short-course regimens containing isoniazid, rifampicin and pyrazinamideTubercle, 1986
- Study of chemotherapy regimens of 5 and 7 months' duration and the role of corticosteroids in the treatment of sputum-positive patients with pulmonary tuberculosis in South IndiaTubercle, 1983
- Ototoxicity with Children caused by StreptomycinInternational Journal of Audiology, 1975